A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Clinical trial NCT01766336 · TERMINATED
Trial details
- NCT number
- NCT01766336
- Sponsor
- OPKO Health, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-08-01
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.